Rigel Pharmaceutical Inc. buy StockNews.com
Start price
05.07.24
/
50%
€0.74
Target price
05.07.25
-
Performance (%)
-
End price
06.07.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rigel Pharmaceutical Inc. | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by StockNews_com for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for RIGL provided by MarketBeat
In the thread Trading Rigel Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.37
12.03.24
12.03.24
-
12.03.25
12.03.25
-43.48%
13.03.25
13.03.25
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.67
27.10.23
27.10.23
-
27.10.24
27.10.24
8.91%
28.10.24
28.10.24
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.00
23.09.23
23.09.23
-
23.09.24
23.09.24
-22.75%
24.09.24
24.09.24